Literature DB >> 21653678

IL-8 signaling plays a critical role in the epithelial-mesenchymal transition of human carcinoma cells.

Romaine I Fernando1, Marianne D Castillo, Mary Litzinger, Duane H Hamilton, Claudia Palena.   

Abstract

The switch of tumor cells from an epithelial to a mesenchymal-like phenotype [designated as epithelial-to-mesenchymal transition (EMT)] is known to induce tumor cell motility and invasiveness, therefore promoting metastasis of solid carcinomas. Although multiple studies have focused on elucidating the signaling events that initiate this phenotypic switch, there has been so far no characterization of the pattern of soluble mediators released by tumor cells undergoing EMT, and the potential impact that this phenotypic switch could have on the remodeling of the tumor microenvironment. Here we show that induction of EMT in human carcinoma cells via overexpression of the transcription factor Brachyury is associated with enhanced secretion of multiple cytokines, chemokines, and angiogenic factors and, in particular, with the induction of the IL-8/IL-8R axis. Our results also indicate the essential role of interleukin 8 (IL-8) signaling for the acquisition and/or maintenance of the mesenchymal and invasive features of Brachyury-overexpressing tumor cells and show that IL-8 secreted by tumor cells undergoing EMT could potentiate tumor progression by inducing adjacent epithelial tumor cells into EMT. Altogether, our results emphasize the potential role of EMT in the modulation of the tumor microenvironment via secretion of multiple soluble mediators and suggest that IL-8 signaling blockade may provide a means of targeting mesenchymal-like, invasive tumor cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21653678      PMCID: PMC3148346          DOI: 10.1158/0008-5472.CAN-11-0156

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  44 in total

Review 1.  Smoldering and polarized inflammation in the initiation and promotion of malignant disease.

Authors:  Frances Balkwill; Kellie A Charles; Alberto Mantovani
Journal:  Cancer Cell       Date:  2005-03       Impact factor: 31.743

Review 2.  Complex networks orchestrate epithelial-mesenchymal transitions.

Authors:  Jean Paul Thiery; Jonathan P Sleeman
Journal:  Nat Rev Mol Cell Biol       Date:  2006-02       Impact factor: 94.444

3.  Transcription repressor slug promotes carcinoma invasion and predicts outcome of patients with lung adenocarcinoma.

Authors:  Jin-Yuan Shih; Meng-Feng Tsai; Tzu-Hua Chang; Yih-Leong Chang; Ang Yuan; Chong-Jen Yu; Shin-Bey Lin; Geou-Yarh Liou; Meng-Larn Lee; Jeremy J W Chen; Tse-Ming Hong; Shuenn-Chen Yang; Jen-Liang Su; Yung-Chie Lee; Pan-Chyr Yang
Journal:  Clin Cancer Res       Date:  2005-11-15       Impact factor: 12.531

Review 4.  Molecular requirements for epithelial-mesenchymal transition during tumor progression.

Authors:  Margit A Huber; Norbert Kraut; Hartmut Beug
Journal:  Curr Opin Cell Biol       Date:  2005-10       Impact factor: 8.382

5.  Up-regulation of TWIST in prostate cancer and its implication as a therapeutic target.

Authors:  Wai Kei Kwok; Ming-Tat Ling; Tak-Wing Lee; Tracy C M Lau; Chun Zhou; Xiaomeng Zhang; Chee Wai Chua; Kwok W Chan; Franky L Chan; Carlotta Glackin; Yong-Chuan Wong; Xianghong Wang
Journal:  Cancer Res       Date:  2005-06-15       Impact factor: 12.701

6.  The human T-box mesodermal transcription factor Brachyury is a candidate target for T-cell-mediated cancer immunotherapy.

Authors:  Claudia Palena; Dmitry E Polev; Kwong Y Tsang; Romaine I Fernando; Mary Litzinger; Larisa L Krukovskaya; Ancha V Baranova; Andrei P Kozlov; Jeffrey Schlom
Journal:  Clin Cancer Res       Date:  2007-04-15       Impact factor: 12.531

Review 7.  TGFbeta signalling: a complex web in cancer progression.

Authors:  Hiroaki Ikushima; Kohei Miyazono
Journal:  Nat Rev Cancer       Date:  2010-06       Impact factor: 60.716

8.  A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes.

Authors:  Richard M Neve; Koei Chin; Jane Fridlyand; Jennifer Yeh; Frederick L Baehner; Tea Fevr; Laura Clark; Nora Bayani; Jean-Philippe Coppe; Frances Tong; Terry Speed; Paul T Spellman; Sandy DeVries; Anna Lapuk; Nick J Wang; Wen-Lin Kuo; Jackie L Stilwell; Daniel Pinkel; Donna G Albertson; Frederic M Waldman; Frank McCormick; Robert B Dickson; Michael D Johnson; Marc Lippman; Stephen Ethier; Adi Gazdar; Joe W Gray
Journal:  Cancer Cell       Date:  2006-12       Impact factor: 31.743

9.  Oncogenic Ras-induced secretion of IL6 is required for tumorigenesis.

Authors:  Brooke Ancrile; Kian-Huat Lim; Christopher M Counter
Journal:  Genes Dev       Date:  2007-07-15       Impact factor: 11.361

10.  Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis.

Authors:  Anke Sparmann; Dafna Bar-Sagi
Journal:  Cancer Cell       Date:  2004-11       Impact factor: 31.743

View more
  175 in total

1.  Differential transcriptomic analysis of spontaneous lung tumors in B6C3F1 mice: comparison to human non-small cell lung cancer.

Authors:  Arun R Pandiri; Robert C Sills; Vincent Ziglioli; Thai-Vu T Ton; Hue-Hua L Hong; Stephanie A Lahousse; Kevin E Gerrish; Scott S Auerbach; Keith R Shockley; Pierre R Bushel; Shyamal D Peddada; Mark J Hoenerhoff
Journal:  Toxicol Pathol       Date:  2012-06-11       Impact factor: 1.902

2.  Interleukin-8 Activates Breast Cancer-Associated Adipocytes and Promotes Their Angiogenesis- and Tumorigenesis-Promoting Effects.

Authors:  Huda H Al-Khalaf; Bothaina Al-Harbi; Adher Al-Sayed; Maria Arafah; Asma Tulbah; Abdulaziz Jarman; Falah Al-Mohanna; Abdelilah Aboussekhra
Journal:  Mol Cell Biol       Date:  2019-01-03       Impact factor: 4.272

3.  Senescent Breast Luminal Cells Promote Carcinogenesis through Interleukin-8-Dependent Activation of Stromal Fibroblasts.

Authors:  Huda H Al-Khalaf; Hazem Ghebeh; Rabia Inass; Abdelilah Aboussekhra
Journal:  Mol Cell Biol       Date:  2019-01-03       Impact factor: 4.272

4.  IL-8 is upregulated in cervical cancer tissues and is associated with the proliferation and migration of HeLa cervical cancer cells.

Authors:  Linlin Jia; Fengying Li; Mingliang Shao; Wei Zhang; Chunbin Zhang; Xiaolian Zhao; Haiyan Luan; Yaling Qi; Pengxia Zhang; Lichun Liang; Xiuyue Jia; Kun Zhang; Yan Lu; Zhe Yang; Xiulin Zhu; Qi Zhang; Jiwei Du; Weiqun Wang
Journal:  Oncol Lett       Date:  2017-11-10       Impact factor: 2.967

5.  Overexpression of the EMT driver brachyury in breast carcinomas: association with poor prognosis.

Authors:  Claudia Palena; Mario Roselli; Mary T Litzinger; Patrizia Ferroni; Leopoldo Costarelli; Antonella Spila; Francesco Cavaliere; Bruce Huang; Romaine I Fernando; Duane H Hamilton; Caroline Jochems; Kwong-Yok Tsang; Qing Cheng; H Kim Lyerly; Jeffrey Schlom; Fiorella Guadagni
Journal:  J Natl Cancer Inst       Date:  2014-05-09       Impact factor: 13.506

6.  The AMPK-activator AICAR in thyroid cancer: effects on CXCL8 secretion and on CXCL8-induced neoplastic cell migration.

Authors:  O Awwad; F Coperchini; P Pignatti; M Denegri; S Massara; L Croce; C A Di Buduo; V Abbonante; A Balduini; L Chiovato; M Rotondi
Journal:  J Endocrinol Invest       Date:  2018-03-15       Impact factor: 4.256

7.  Dynamic interplay between tumour, stroma and immune system can drive or prevent tumour progression.

Authors:  R J Seager; Cynthia Hajal; Fabian Spill; Roger D Kamm; Muhammad H Zaman
Journal:  Converg Sci Phys Oncol       Date:  2017-07-28

8.  Neurotensin/IL-8 pathway orchestrates local inflammatory response and tumor invasion by inducing M2 polarization of Tumor-Associated macrophages and epithelial-mesenchymal transition of hepatocellular carcinoma cells.

Authors:  Pei Xiao; Xinxin Long; Lijie Zhang; Yingnan Ye; Jincheng Guo; Pengpeng Liu; Rui Zhang; Junya Ning; Wenwen Yu; Feng Wei; Jinpu Yu
Journal:  Oncoimmunology       Date:  2018-03-13       Impact factor: 8.110

9.  Hydroxyapatite mineral enhances malignant potential in a tissue-engineered model of ductal carcinoma in situ (DCIS).

Authors:  Frank He; Nora L Springer; Matthew A Whitman; Siddharth P Pathi; Yeonkyung Lee; Sunish Mohanan; Stephen Marcott; Aaron E Chiou; Bryant S Blank; Neil Iyengar; Patrick G Morris; Maxine Jochelson; Clifford A Hudis; Pragya Shah; Jennie A M R Kunitake; Lara A Estroff; Jan Lammerding; Claudia Fischbach
Journal:  Biomaterials       Date:  2019-09-11       Impact factor: 12.479

10.  An integrated functional genomics approach identifies the regulatory network directed by brachyury (T) in chordoma.

Authors:  Andrew C Nelson; Nischalan Pillay; Stephen Henderson; Nadège Presneau; Roberto Tirabosco; Dina Halai; Fitim Berisha; Paul Flicek; Derek L Stemple; Claudio D Stern; Fiona C Wardle; Adrienne M Flanagan
Journal:  J Pathol       Date:  2012-09-26       Impact factor: 7.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.